Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2017

Feb 16, 2017

30339_dirs_2017-02-16_6b32af32-2441-4e2c-8e2a-08c04d5cd1c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-02-14

Reporting Person: Malone Daniel (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-14 Common Stock A 943.00 $86.93 Acquired 27726.8866 Direct
2017-02-14 Common Stock A 1272.00 $86.93 Acquired 28998.8866 Direct

Footnotes

F1: Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F3: Bonus and incentive shares granted on 02/14/2017.